The TME-derived TGF-β can induce NK cells to transdifferentiate into innate lymphoid cell (ILC) type 1 cells (ILC1), which have no cytotoxic activity, thus promoting tumor escape from immune attack (33). Here, TGFB1 is linked to neoplasm.